8-KOther Events

ELI LILLY & Co 8-K Report (Jun 12, 1995)

Filed June 12, 1995For Securities:LLY

Summary

This 8-K filing from Eli Lilly & Co. on June 12, 1995, primarily serves as a notification of a material event occurring on June 5, 1995. While the provided text is a directory listing from the SEC's EDGAR system and does not contain the specific details of the event itself, 8-K filings are crucial for investors as they signal significant corporate developments that could impact the company's stock price and future performance. These events can range from mergers and acquisitions to significant financial changes, executive appointments, or material agreements.

Key Highlights

  • 1The filing is an 8-K Current Report, indicating a material event that requires prompt disclosure to investors.
  • 2The event date is reported as June 5, 1995, with the filing date on June 11, 1995, adhering to SEC disclosure timelines.
  • 3As a standard 8-K, this report likely contains information about a significant corporate action or development.
  • 4Investors should consult the full 8-K document to understand the specific details of the reported event and its potential implications.
  • 5The filing originates from Eli Lilly & Co. (LLY), a major pharmaceutical company.
  • 6The filing was made on the SEC's EDGAR system, accessible to the public.

Frequently Asked Questions

An 8-K filing is a report of unscheduled material events or corporate changes that could be of importance to shareholders and the investing public. Companies are required to file an 8-K within a specific timeframe after the event occurs to ensure timely disclosure.

The provided text is a directory listing from the SEC's EDGAR system and does not contain the specific details of the material event itself. Investors would need to access the actual 8-K document (often a .txt file referenced in such listings) to understand the nature of the event.

This filing indicates a significant development within Eli Lilly that management deems material enough to warrant immediate public disclosure. Understanding the nature of this event is crucial for investors to assess its potential impact on the company's financial health, strategic direction, and stock valuation.

The full details of the 8-K filing can typically be found by searching the SEC's EDGAR database for Eli Lilly & Co. (LLY) filings around the date of June 11, 1995. The provided directory listing may contain links or references to the actual document, likely in a .txt format.